Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia

Clinical and Experimental Dermatology

Volumn 34, Issue 7, 2009, Pages 781-783

  Ashida, R ^a   Ihn, H ^a,b   Mimura, Y ^a   Jinnin, M ^a   Asano, Y ^a   Kubo, M ^a,c   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCINOSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; ESOPHAGUS; FEMALE; HEART; HUMAN; JAPANESE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCAR; SCHOOL CHILD; SCLERODERMA; TELANGIECTASIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCINOSIS; CHILD; ESOPHAGEAL DISEASES; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; SCLERODERMA, SYSTEMIC; TELANGIECTASIS; YOUNG ADULT;

EID: 70349515172     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03148.x     Document Type: Article

References (12)

1. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 1986 231 : 737 740.
2. Ihn H, Yamane K, Yazawa N et al. Distribution and antigen specificity of anti-U1 RNP antibodies in patients with systemic sclerosis. Clin Exp Immunol 1999 117 : 383 387.
3. Clark JA, Winkelmann R, McDuffie FC, Ward LE. Synovial tissue changes and rheumatoid factor in scleroderma. Mayo Clin Proc 1971 46 : 97 103.
4. Sato S, Ihn H, Kikuchi K, Takehara K. Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis. Arthritis Rheum 1994 37 : 391 394.
5. Serup J, Staun-Olsen P. Antinuclear antibodies and anti-DNA antibodies in scleroderma. Allergy 1986 41 : 452 456.
6. Yamane K, Ihn H, Asano Y et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 2000 39 : 1269 1271.
7. Ashida R, Ihn H, Mimura Y et al. Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol 2007 26 : 1275 1277.
8. Krishna Sumanth M, Sharma VK, Khaitan BK et al. Evaluation of oral methotrexate in the treatment of systemic sclerosis. Int J Dermatol 2007 46 : 218 223.
9. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988 15 : 202 205.
10. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988 31 : 196 203.
11. Ihn H, Sato S, Fujimoto M et al. Measurement of anticardiolipin antibodies by ELISA using β2-glycoprotein I (β2-GPI) in systemic sclerosis. Clin Exp Immunol 1996 105 : 475 479.
12. Steen VD, Ziegler GL, Rodnan GP et al. Clinical and laboratory association of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984 27 : 125 131.